Arena Pharmaceuticals Inc (NASDAQ:ARNA)

49.68
Delayed Data
As of Oct 21
 +0.87 / +1.77%
Today’s Change
31.97
Today|||52-Week Range
64.48
+27.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Operating ActivitiesNet Income / Starting Line-34.3M68.7M620.1M-61.4M
 
 
 
 
 
Depreciation961.0K896.0K764.0K791.0K
 
 
 
 
 
Total Other Cash Flow2.7M3.5M11.9M11.2M
 
 
 
 
 
Funds From Operations-30.6M-37.3M743.1M-49.4M
 
 
 
 
 
Funds From/For Other Operating Expenses394.0K-3.6M5.5M5.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-31.0M-33.7M737.7M-55.1M
 
 
 
 
 
 
InvestingIncrease In Investments-102.0K-339.0M-249.5M-660.2M
 
 
 
 
 
Decrease In Investments38.1M25.5M76.1M183.7M
 
 
 
 
 
Capital Expenditures-40.0K-124.0K-1.1M-839.0K
 
 
 
 
 
Other Investing - Uses0.00-11.0K0.000.00
 
 
Other Investing - Sources-1.0K-1.0K0.00997.0K
 
 
 
 
Net Cash Flow Investing38.0M-313.6M-174.5M-476.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-1.1M-968.0K-760.0K-810.0K
 
 
 
 
 
Net Proceeds Stock Sale1.5M552.0K3.4M4.7M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing414.0K-416.0K2.6M3.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash65.0K41.0K-18.0K7.0K
 
 
 
 
 
 
Net Change In Cash7.4M-347.7M565.7M-527.6M